Pharmaxo Drugs Private Limited - Company Profile

It is a paper private limited company based in Kagal, Maharashtra, India, established in 2023.
2023 Kagal, Maharashtra, India Active
Last Updated:
Access Report
About Pharmaxo Drugs Private Limited

Pharmaxo Drugs Private Limited, a active private limited company, was established on 17 November 2023 in Kagal, Maharashtra, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21004PN2023PTC225675. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Rounak Pratap (Director), Saorav Kumar (Director), Sanjay Namdev Jadhav (Director). Past directors included Jitendra Suryakant Pawar. It is based at Plot No D-112, Five Star, Midc Kagal Hatkanagle, Kagal, Maharashtra, 416216.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21004PN2023PTC225675

  • Registration Number

    225675

  • Incorporation Date

    17 November 2023

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 4 Months
Company report

Pharmaxo Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Pharmaxo Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Pharmaxo Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Rounak Pratap Director 17 Nov 2023 Current
Saorav Kumar Director 17 Nov 2023 Current
Sanjay Namdev Jadhav Director 17 Nov 2023 Current
Vinayak Dattatray Patil Director 17 Nov 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pharmaxo Drugs.

Enhance accessibility to Pharmaxo Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Pharmaxo Drugs revenue growth over time
Pharmaxo Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pharmaxo Drugs?

Unlock access to Pharmaxo Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Pharmaxo Drugs?

Unlock and access historical data on people associated with Pharmaxo Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pharmaxo Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmaxo Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pharmaxo Drugs
Recent Activity within the Organization
  • Director Appointment

    Rounak Pratap was appointed as a Director was appointed as a Director on 17 Nov 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.

  • Director Appointment

    The activity Saorav Kumar was appointed as a Director was appointed as a Director on 17 Nov 2023 & has been associated with this company since 2 years 4 months . was completed.

  • Director Appointment

    Sanjay Namdev Jadhav was appointed as a Director was appointed as a Director on 17 Nov 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.

  • Director Appointment

    Vinayak Dattatray Patil was appointed as a Director was appointed as a Director on 17 Nov 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Pharmaxo Drugs Private Limited was registered on 17 Nov 2023 with Roc Pune & aged 2 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Pharmaxo Drugs Private Limited?

The CIN of Pharmaxo Drugs Private Limited is U21004PN2023PTC225675.

Where is Pharmaxo Drugs Private Limited headquartered?

Pharmaxo Drugs Private Limited is headquartered at Plot No D-112, Five Star, Midc Kagal Hatkanagle, Kagal, Maharashtra, 416216.

When was Pharmaxo Drugs Private Limited incorporated?

Pharmaxo Drugs Private Limited was incorporated on 17 November 2023.

Who are the current directors of Pharmaxo Drugs Private Limited?

The current directors of Pharmaxo Drugs Private Limited are

What is the primary industry of Pharmaxo Drugs Private Limited?

The primary industry of Pharmaxo Drugs Private Limited is Paper.

Is Pharmaxo Drugs Private Limited a listed company?

Pharmaxo Drugs Private Limited is unlisted.

What is the capital structure of Pharmaxo Drugs Private Limited?

The authorized capital of Pharmaxo Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available